// App-Quantinova.ai

: Incidence of multiple progression events in patients with idiopathic pulmonary fibrosis (IPF) in the pooled CAPACITY and ASCEND trials

Researchers

Presenter

  • Steven Nathan

Principal Investigators

  • Ulrich Costabel

  • Ian Glaspole

  • Marilyn K. Glassberg

  • Lisa H. Lancaster

  • David J. Lederer

  • Carlos A. Pereria

  • Ben Trzaskoma

  • Susan Limb

  • Athol U. Wells

Medical Centers

  • Inova Fairfax Hospital, Falls Church, VA, United States of America

  • Ruhrlandklinik, University Hospital, University of Duisburg-Essen, Essen, Germany

  • The Alfred Hospital and Monash University, Melbourne, Australia

  • University of Miami Miller School of Medicine, Miami, Florida, United States

  • Vanderbilt University, Medical Center, Nashville, United States

  • Columbia University, New York, New York, United States

  • Federal Univ. of Sao Paulo, Sao Paulo, Brazil.

  • Genentech Inc., San Francisco, United States

  • Royal Brompton Hospital, Interstitial Lung Disease Unit, London, United Kingdom

Locations

  • United States

  • Germany

  • Australia

  • Brazil

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

Disease

  • Idiopathic pulmonary fibrosis

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • III

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved